Stefano R. Tarantolo
Hematology | Oncology
8303 Dodge St Ste 250
Omaha, NE 68114
Omaha, NE 68114
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.
Journal: Leukemia & lymphoma
Published: March 28, 2015
Immunological effects and therapeutic role of C5a in cancer.
Journal: Expert review of clinical immunology
Published: November 13, 2014
Phase 1b study of otlertuzumab (TRU-016), an anti-CD37 monospecific ADAPTIR™ therapeutic protein, in combination with rituximab and bendamustine in relapsed indolent lymphoma patients.
Journal: Investigational new drugs
Published: April 16, 2014
Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT).
Journal: Bone marrow transplantation
Published: July 10, 2012
Incidence and prognostic significance of second primary cancers in renal cell carcinoma.
Journal: American journal of clinical oncology
Published: March 24, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026